Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18)

被引:117
|
作者
van Egmond, M
van Vuuren, AJH
Morton, HC
van Spriel, AB
Shen, L
Hofhuis, FMA
Saito, T
Mayadas, TN
Verbeek, JS
van de Winkel, JGJ
机构
[1] Univ Utrecht, Med Ctr, Dept Immunol, Immunotherapy Lab, NL-3584 EA Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Medarex Europe, Utrecht, Netherlands
[3] Univ Oslo, Dept Immunohistochem & Immunopathol, Oslo, Norway
[4] Dartmouth Med Sch, Dept Immunol & Microbiol, Lebanon, NH USA
[5] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba, Japan
[6] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1182/blood.V93.12.4387.412k08_4387_4394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Even though more immunoglobulin A (IgA) is produced in humans than all other isotypes combined, relatively little is known about receptors that bind the Fc part of IgA. The myeloid IgA receptor, Fc alpha RI (CD89), triggers various effector functions in vitro, but its in vivo role remains unclear. Here, a transgenic mouse model is described in which Fc alpha RI is expressed under its own regulatory sequences, Receptor expression and regulation by cytokines was comparable to the human situation and hFc alpha RI can trigger phagocytosis and lysis of tumor cells, To analyze the contribution of the FcR gamma chain or the beta 2 integrin CR3 (CD11b/CD18) in Fc alpha RI biological function, Fc alpha RI transgenic mice were crossed with either FcR gamma chain -/- or CR3 -/- mice. In contrast to in vitro data, FcR gamma chain was essential for surface expression of hFc alpha RI in vivo, Functional studies in hFc alpha RI/gamma-/-mice were, therefore, limited. In vitro studies showed FcR gamma chain to be necessary for phagocytosis. Neither hFc alpha RI expression nor phagocytosis, triggered via hFc alpha RI, were influenced by CR3. Remarkably, the capacity to lyse tumor targets was ablated in hFc alpha RI transgenic/CR3-/- mice, although binding of neutrophils to tumor cells was intact. This shows a previously unrecognized importance of CR3 for hFc alpha RI-mediated antibody-dependent cellular cytotoxicity (ADCC). (C) 1999 by The American Society of Hematology.
引用
收藏
页码:4387 / 4394
页数:8
相关论文
共 50 条
  • [41] The urokinase receptor interacts with the extracellular domain of the CD11b subunit and modulates Mac-1 (CD11b/CD18) function
    Rao, NK
    Xu, H
    Bodary, S
    Ortlepp, S
    Chapman, HA
    Simon, DI
    CIRCULATION, 1997, 96 (08) : 191 - 191
  • [42] SIGNALING PROPERTIES OF CR3 (CD11B/CD18) AND CR-1 (CD35) IN RELATION TO PHAGOCYTOSIS OF COMPLEMENT-OPSONIZED PARTICLES
    FALLMAN, M
    ANDERSSON, R
    ANDERSSON, T
    JOURNAL OF IMMUNOLOGY, 1993, 151 (01): : 330 - 338
  • [43] BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1
    Nagy-Balo, Zsuzsa
    Kiss, Richard
    Demeter, Judit
    Bodor, Csaba
    Bajtay, Zsuzsa
    Erdei, Anna
    PLOS ONE, 2021, 16 (07):
  • [44] THE LEUKOCYTE INTEGRIN AND COMPLEMENT RECEPTOR CR3 (CD11B/CD18) HAS SPECIFICITY FOR C3DG, AS WELL AS FOR IC3B
    ROSS, GD
    REED, W
    FASEB JOURNAL, 1992, 6 (05): : A2013 - A2013
  • [45] ADHERENCE OF HUMAN MONOCYTES TO HEMODIALYSIS MEMBRANES - LFA-1 (CD11A/CD18) CR-1 (CD35) AND CR3 (CD11B/CD18) TRIGGERING PROMOTES THE BIOSYNTHESIS OF PLATELET-ACTIVATING-FACTOR AND ADHERENCE
    TETTA, C
    TROPEA, F
    CAMUSSI, G
    NERI, R
    WRATTEN, ML
    SERENI, L
    SILVESTRO, L
    FRANCESCHI, C
    HAEFFNERCAVAILLON, N
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (09) : 1679 - 1688
  • [46] INDUCTION OF CELL-ASSOCIATED INTERLEUKIN-1 THROUGH STIMULATION OF THE ADHESION-PROMOTING PROTEINS LFA-1 (CD11A/CD18) AND CR3 (CD11B/CD18) OF HUMAN MONOCYTES
    COUTURIER, C
    HAEFFNERCAVAILLON, N
    WEISS, L
    FISCHER, E
    KAZATCHKINE, MD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (05) : 999 - 1005
  • [47] THE WI-1 ANTIGEN OF BLASTOMYCES-DERMATITIDIS YEASTS MEDIATES BINDING TO HUMAN MACROPHAGE CD11B/CD18 (CR3) AND CD14
    NEWMAN, SL
    CHATURVEDI, S
    KLEIN, BS
    JOURNAL OF IMMUNOLOGY, 1995, 154 (02): : 753 - 761
  • [48] SELECTIVE MODULATION OF CD15S AND CR3 (CD11B/CD18) ON MONOCYTES AND NEUTROPHILS IN PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
    CARRENO, MP
    STUART, S
    POIGNET, JL
    CHAUVEAU, P
    HAEFFNERCAVAILLON, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 438 - 438
  • [49] Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18)
    Svoboda, Eliska
    Schneider, Andrea E.
    Sandor, Noemi
    Lermann, Ulrich
    Staib, Peter
    Kremlitzka, Mariann
    Bajtay, Zsuzsa
    Barz, Dagmar
    Erdei, Anna
    Jozsi, Mihaly
    IMMUNOLOGY LETTERS, 2015, 168 (01) : 13 - 21
  • [50] Cutting edge: Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice
    Rosenkranz, AR
    Coxon, A
    Maurer, M
    Gurish, MF
    Austen, KF
    Friend, DS
    Galli, SJ
    Mayadas, TN
    JOURNAL OF IMMUNOLOGY, 1998, 161 (12): : 6463 - 6467